肠道微生物组与肠道屏障对肝病的贡献
本文综述了调节肠道通透性的机制以及肠道微生物组变化如何促进急性和慢性肝病的发生发展,讨论了肠道屏障的各个组成部分及其在不同肝病发展过程中如何被破坏。
要点
- 肠道屏障的物理、免疫和微生物学特征将约100万亿微生物与人体其余部分隔开。
- 屏障任何方面的失效可导致微生物易位入血并引发持续炎症反应,促进肝损伤、纤维化、肝硬化和致癌转化。
- 肠道微生物种群或其功能的改变也可影响健康。
核心结论
- 肠道屏障功能障碍和菌群失调促进肝脏及其他器官疾病的发生发展。
研究设计与样本
- 综述,检索范围未在原文中明确报告。
主要发现
- 肠道屏障的物理、免疫和微生物学(细菌、真菌、古菌、病毒和原虫)特征将约100万亿微生物与人体其余部分隔开。
- 屏障任何方面的失效可导致微生物易位入血和持续炎症反应,促进肝损伤、纤维化、肝硬化和致癌转化。
- 肠道微生物种群或其功能的改变也可影响健康。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intestinal barrier dysfunction and dysbiosis contribute to development of diseases in liver and other organs. Physical, immunologic, and microbiologic (bacterial, fungal, archaeal, viral, and protozoal) features of the intestine separate its nearly 100 trillion microbes from the rest of the human body. Failure of any aspect of this barrier can result in translocation of microbes into the blood and sustained inflammatory response that promote liver injury, fibrosis, cirrhosis, and oncogenic transformation. Alterations in intestinal microbial populations or their functions can also affect health. We review the mechanisms that regulate intestinal permeability and how changes in the intestinal microbiome contribute to development of acute and chronic liver diseases. We discuss individual components of the intestinal barrier and how these are disrupted during development of different liver diseases. Learning more about these processes will increase our understanding of the interactions among the liver, intestine, and its flora.
引用
- Chopyk DM, Grakoui A. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology. 2020. PMID: 32569766. doi:10.1053/j.gastro.2020.04.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。